Produktname:(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide
IUPAC Name:1-{3-cyano-4-[(E)-[(dimethylamino)methylidene]amino]phenyl}-3-(1-hydroxy-2-methylpropan-2-yl)thiourea
- CAS:1429755-57-6
- Molekulare Formel:C15H21N5OS
- Reinheit:95%+
- Katalognummer:CM329512
- Molekulargewicht:319.43
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1429755-57-6
- Molekulare Formel:C15H21N5OS
- Schmelzpunkt:-
- SMILES-Code:CN(C)/C=N/C1=CC=C(NC(NC(C)(C)CO)=S)C=C1C#N
- Dichte:
- Katalognummer:CM329512
- Molekulargewicht:319.43
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:Keep in a tight container and store at abient temperature
Column Infos
- Tucatinib
- In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.